1-4 of 4
Anita W. Rijneveld
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tyrosine kinase inhibitor resistance in de novo BCR :: ABL1 –positive BCP-ALL beyond kinase domain mutations

Clinical Trials & Observations
Inge van Outersterp, Judith M. Boer, Cesca van de Ven, Caitlin E. J. Reichert, Aurelie Boeree, Brian Kruisinga, Hester A. de Groot-Kruseman, Gabriele Escherich, Aniko Sijs-Szabo, Anita W. Rijneveld, Monique L. den Boer
Journal: Blood Advances
Blood Adv (2024) 8 (8): 1835–1845.
https://doi.org/10.1182/bloodadvances.2023012162
Published: 2024
Includes: Supplemental data
Journal Articles

Oxygen gradient ektacytometry–derived biomarkers are associated with acute complications in sickle cell disease

Clinical Trials & Observations
Minke A. E. Rab, Celeste K. Kanne, Camille Boisson, Jennifer Bos, Brigitte A. van Oirschot, Maite E. Houwing, Céline Renoux, Marije Bartels, Anita W. Rijneveld, Erfan Nur, Marjon H. Cnossen, Philippe Joly, Elie Nader, Romain Fort, Philippe Connes, Richard van Wijk, Vivien A. Sheehan, Eduard J. van Beers
Journal: Blood Advances
Blood Adv (2024) 8 (2): 276–286.
https://doi.org/10.1182/bloodadvances.2023011013
Published: 2024
Includes: Supplemental data
Journal Articles

One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study

Clinical Trials & Observations
Myrthe J. van Dijk, Minke A. E. Rab, Brigitte A. van Oirschot, Jennifer Bos, Cleo Derichs, Anita W. Rijneveld, Marjon H. Cnossen, Erfan Nur, Bart J. Biemond, Marije Bartels, Judith J. M. Jans, Wouter W. van Solinge, Roger E. G. Schutgens, Richard van Wijk, Eduard J. van Beers
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7539–7550.
https://doi.org/10.1182/bloodadvances.2023011477
Published: 2023
Includes: Supplemental data
Journal Articles

Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial

Clinical Trials & Observations
Anita W. Rijneveld, Bronno van der Holt, Okke de Weerdt, Bart J. Biemond, Arjen A. van de Loosdrecht, Lotte E. van der Wagen, Mar Bellido, Michel van Gelder, Walter J. F. M. van der Velden, Dominik Selleslag, Daniëlle van Lammeren-Venema, Constantijn J. M. Halkes, Rob Fijnheer, Violaine Havelange, Geerte L. van Sluis, Marie-Cecile Legdeur, Dries Deeren, Alain Gadisseur, Harm A. M. Sinnige, Dimitri A. Breems, Aurélie Jaspers, Ollivier Legrand, Wim E. Terpstra, Rinske S. Boersma, Dominiek Mazure, Agnes Triffet, Lidwine W. Tick, Karolien Beel, Johan A. Maertens, H. Berna Beverloo, Marleen Bakkus, Christa H. E. Homburg, Valerie de Haas, Vincent H. J. van der Velden, Jan J. Cornelissen, the Dutch-Belgian HOVON Cooperative group
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1115–1125.
https://doi.org/10.1182/bloodadvances.2021005624
Published: 2022
Includes: Supplemental data